Discussion on Pathogenesis and Treatment of Type 2 Diabetes from Perspective of Intestinal Microecology

Yun HE; Li-xia YANG; Lian-li QIU

doi:10.13422/j.cnki.syfjx.20201538

您当前的位置：

首页 >

文章列表页 >

Discussion on Pathogenesis and Treatment of Type 2 Diabetes from Perspective of Intestinal Microecology

Review | 更新时间：2020-08-11

- Discussion on Pathogenesis and Treatment of Type 2 Diabetes from Perspective of Intestinal Microecology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 15, Pages: 229-234(2020)
- 作者机构：
  
  1.甘肃中医药大学，兰州 730000
  2.甘肃省中医药研究院，兰州 730020
  3.甘肃省中医院，兰州 730699
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201538
  CLC： R2-0;R285.5;G353.11;R587.1
- Revised：15 October 2019，
  
  Published Online：27 May 2020，
  
  Published：05 August 2020
- 稿件说明：
移动端阅览
贺云,杨丽霞,邱连利.从肠道微生态角度探讨2型糖尿病的发病机制以及治疗措施[J].中国实验方剂学杂志,2020,26(15):229-234.

HE Yun,YANG Li-xia,QIU Lian-li.Discussion on Pathogenesis and Treatment of Type 2 Diabetes from Perspective of Intestinal Microecology[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(15):229-234.
贺云,杨丽霞,邱连利.从肠道微生态角度探讨2型糖尿病的发病机制以及治疗措施[J].中国实验方剂学杂志,2020,26(15):229-234. DOI： 10.13422/j.cnki.syfjx.20201538.

HE Yun,YANG Li-xia,QIU Lian-li.Discussion on Pathogenesis and Treatment of Type 2 Diabetes from Perspective of Intestinal Microecology[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(15):229-234. DOI： 10.13422/j.cnki.syfjx.20201538.

摘要

糖尿病是对人类健康构成极大威胁的一类疾病，其发生、发展往往与遗传和环境等多种因素有关。根据2017年第八版糖尿病联合会糖尿病图谱显示全世界约有4.25亿糖尿病患者，预计到2045年，糖尿病患者将会增加到7亿，成为一个日益引起全世界关注的健康问题。其中，2型糖尿病患者人数占总人数的90%以上，因此，研究病理机制对于有效预防和治疗2型糖尿病具有重要意义。肠道菌群与人类共存，为人类重要的微生态系统，参与人体物质和能量代谢。近年来，随着高通量测序技术的发展，大量研究表明除了肥胖、遗传和胰岛素功能紊乱外，肠道菌群紊乱也可能导致糖尿病。2型糖尿病患者不平衡的饮食结构破坏了肠道菌群的平衡，一般认为，2型糖尿病的发生发展可能是营养过剩引起肠道微生物紊乱的结果之一。但是，肠道菌群是如何参与2型糖尿病的发生发展尚未有明确的机制。目前，普遍认为肠道菌群可能通过参与胆汁酸代谢、短链脂肪酸代谢、低水平的炎症反应等途径影响了机体的代谢。对于2型糖尿病的预防和治疗目前主要以药物控制为主，通过外科手术、增加益生菌、粪便移植等方法干预肠道菌群来调整肠道微生态为2型糖尿病的预防和治疗提供了新手段，本文就近年来有关2型糖尿病与肠道微生态之间的相互作用以及未来可能的治疗措施进行综述。

Abstract

Diabetes is a kind of disease which poses a great threat to human health. Its occurrence and development are often related to many factors such as heredity and environment. According to the eighth edition of Diabetes Federation's diabetes map in 2017， there are about 425 million diabetics in the world. It is estimated that by 2045， the number of diabetics will increase to 700 million， becoming a health problem that has attracted increasing attention all over the world， among which the number of type 2 diabetics （T2DM）accounts for more than 90% of the total. Therefore， it is of great significance to study the pathological mechanism for the effective prevention and treatment of diabetes. Intestinal microflora coexists with human beings and forms an important micro ecosystem， which is involved in the metabolism of substance and energy. In recent years， with the development of high-throughput sequencing technology， a large number of studies have shown that in addition to obesity， genetic and insulin dysfunction， intestinal flora disorder may also lead to diabetes. The unbalanced diet structure of T2DM patients destroys the balance of intestinal flora. It is generally believed that the occurrence and development of T2DM may be one of the results of the intestinal microbial disorder caused by over nutrition. However， there is no clear mechanism of how intestinal flora participates in the development of T2DM. At present， it is generally believed that the intestinal flora may affect the metabolism of the body through the participation in bile acid metabolism， short chain fatty acid metabolism， low-level inflammatory response and other ways. At present， the prevention and treatment of T2DM is mainly based on drug control. Through surgical operation， increasing the number of probiotics， fecal transplantation and other methods to intervene the intestinal microflora to adjust the intestinal microflora， it provides a new means for the prevention and treatment of T2DM. This paper discusses the interaction between T2DM and intestinal microflora in recent years and the possible treatment measures in the future.

关键词

Keywords

references

ASSOCIATION A D . Diagnosis and classification of diabetes mellitus ［J］. Diabetes Care ， 2010 ， doi： 10.2337/dc10-S062 http://dx.doi.org/10.2337/dc10-S062 .

LYNCH S V ， PEDERSEN O . The human intestinal microbiome in health and disease ［J］. N Engl J Med ， 2016 ， 375 （ 24 ）： 2369 - 2379 .

MA Q T ， LI Y Q ， LI P F ， et al . Research progress in the relationship between type 2 diabetes mellitus and intestinal flora ［J］. Biomed Pharmacoth ， 2019 ， 117 ： 109138 .

SEBASTIAN D J J ， SANCHEZ S C . From the intestinal flora to the microbiome ［J］. Rev Esp Enferm Dig ， 2018 ， 110 （ 1 ）： 51 - 56 .

MILANI C ， DURANTI S ， BOTTACINI F ， et al . The first microbial colonizers of the human gut：composition，activities，and health implications of the infant gut microbiota ［J］. Microbio Mol Biol Rev ， 2017 ， 81 （ 4 ）： 1 - 67 .

D'ARGENIO V ， SALVATORE F . The role of the gut microbiome in the healthy adult status ［J］. Clinica Chimica Acta ， 2015 ， 451 ： 97 - 102 .

SHI N ， LI N ， DUAN X W ， et al . Interaction between the gut microbiome and mucosal immune system ［J］. Mil Med Res ， 2017 ， 4 （ 3 ）： 170 - 177 .

BARKO P C ， MCMICHAEL M A ， SWANSON K S ， et al . The gastrointestinal microbiome：a review ［J］. J Vet Intern Med ， 2018 ， 32 （ 1 ）： 9 - 25 .

HORIE M ， MIURA T ， HIRAKATA S ， et al . Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice ［J］. Experimental Animals ， 2017 ， 66 （ 4 ）： 405 - 416 .

VALLABH S ， LAMBETH S M ， TRECHELLE C ， et al . Composition diversity and abundance of gut microbiome in prediabetes and type 2 diabete ［J］. J Diabetes ， 2015 ， 2 （ 2 ）： 108 - 114 .

CATOI A F ， PARVU A ， MURESAN A ， et al . Metabolic mechanisms in obesity and type 2 diabetes： insights from bariatric/metabolic surgery ［J］. Obes Facts ， 2015 ， 8 （ 6 ）： 350 - 363 .

BATTERHAM R L ， CUMMINGS D E . Mechanisms of diabetes improvement following bariatric/metabolic surgery ［J］. Diabetes Care ， 2016 ， 39 （ 6 ）： 893 - 901 .

RAMÍREZ-PÉREZ O ， CRUZ-RAMÓN V ， CHINCHILLA-LÓPEZ P ， et al . The role of the gut microbiota in bile acid metabolism ［J］. Ann Hepatol ， 2017 ， 16 （ S1 ）： 15 - 20 .

LUKASZ K ， TOMASZ S ， AGNIESZKA C ， et al . Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome ［J］. World J Gastroentero ， 2016 ， 22 （ 39 ）： 8698 - 8719 .

STALEY C ， WEINGARDEN A R ， KHORUTS A ， et al . Interaction of gut microbiota with bile acid metabolism and its influence on disease states ［J］. App Microbio Biotechnol ， 2017 ， 101 （ 1 ）： 47 - 64 .

HU J M ， LIN S L ， ZHENG B D ， et al . Short-chain fatty acids in control of energy metabolism ［J］. Crit Rev Food Sci Nutr ， 2018 ， 58 （ 8 ）： 1243 - 1249 .

CANFORA E E ， JOCKEN J W ， BLAAK E E . Short-chain fatty acids in control of body weight and insulin sensitivity ［J］. Nat Rev Endocrinol ， 2015 ， 11 （ 10 ）： 577 - 591 .

OHIRA H ， FUJIOKA Y ， KATAGIRI C ， et al . Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages ［J］. J Atheroscler Thromb ， 2013 ， 20 （ 5 ）： 425 - 442 .

SAHURI-ARISOYLU M ， BRODY L P ， PARKINSON J R ， et al . Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate ［J］. Int J Obes ， 2016 ， 40 （ 6 ）： 955 - 963 .

CANFORA E E ， VAN D B C M ， JOCKEN J W E ， et al . Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men： a randomized crossover trial ［J］. Sci Rep ， 2017 ， 7 （ 1 ）： 2360 .

LI W ， DUFFY A . Factors influencing the gut microbiota，inflammation，and type 2 diabetes ［J］. J Nutr ， 2017 ， 147 （ 7 ）： 1468 S-1 475S .

CANI P D ， OSTTO M ， GEURTS L ， et al . Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity ［J］. Gut Microbes ， 2012 ， 3 （ 4 ）： 279 - 288 .

HARSCH I A ， KONTUREK P C . The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus： new insights into "old" diseases ［J］. Med Sci ， 2018 ， 6 （ 2 ）： 32 .

JACQUES A ， CHABO C ， AURELIE W ， et al . Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes：molecular mechanisms and probiotic treatment ［J］. EMBO Mol Med ， 2011 ， 3 （ 9 ）： 559 - 572 .

SANCHEZ-RANGEL E ， INZUCCHI ， SILVIO E . Metformin：clinical use in type 2 diabetes ［J］. Diabetologia ， 2017 ， 60 （ 9 ）： 1586 - 1593 .

CEFALU W T ， NAUCK M A ， BUSE J B ， et al . Beyond metformin：safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management reflections from a diabetes care editors' expert forum ［J］. Diabetes Care ， 2014 ， 37 （ 9 ）： 2647 - 2659 .

LEE H ， KO G P . Effect of metformin on metabolic improvement and gut microbiota ［J］. Appl Environ Microbiol ， 2014 ， 80 （ 19 ）： 5935 - 5943 .

SHIN N R ， LEE J C ， LEE H Y ， et al . An increase in the akkermansia spp.population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice ［J］. Gut ， 2014 ， 63 （ 5 ）： 727 - 735 .

CUMMINGS D E ， RUBINO F ， METABOLIC . Surgery for the treatment of type 2 diabetes in obese individuals ［J］. Diabetologia ， 2018 ， 61 （ 2 ）： 257 - 264 .

MILONE M ， DI M M N D ， LEONGITO M ， et al . Bariatric surgery and diabetes remission： sleeve gastrectomy or mini-gastric bypass ［J］. World J Gastroentero ， 2013 ， 19 （ 39 ）： 6590 - 6597 .

WANG Y ， WU Y P ， WANG Y Y ， et al . Antioxidant properties of probiotic bacteria ［J］. Nutrients ， 2017 ， 9 （ 5 ）： E521 .

ALINE C C ， ALLAIN A B ， JOAO F ， M ， et al . Gut microbiota，probiotics and diabetes ［J］. Nutr J ， 2014 ， 13 ： 60 .

EVERARD A ， BELZER C ， GEURTS L . Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity ［J］. Proc Natl Acad Sci USA ， 2013 ， 110 （ 22 ）： 9066 - 9071 .

MULLA C M ， MIDDELBEEK R J W ， PATTI M E ， et al . Mechanisms of weight loss and improved metabolism following bariatric surgery ［J］. Ann N Y Acad Sci ， 2018 ， 1411 （ 1 ）： 53 - 64 .

LIN L ， ZHANG J . Role of intestinal microbiota and metabolites on gut homeostasis and human diseases ［J］. BMC Immunol ， 2017 ， 18 （ 1 ）： 2 .

SIDHU M ， DAVID V D P . The gut microbiome ［J］. Aust Fam Physician ， 2017 ， 46 （ 4 ）： 206 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Paeonol in Alleviating Alcohol-induced Liver Injury in Mice Through Regulating SCFAs-GPR43/MAPK Signaling Pathway Mediated by Intestinal Flora

Effect of Huangling Jidu Xizhuo Granules on NLRP3， Intestinal Flora and Short-term Prognosis in Patients with Gout

Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review

Mechanisms of Intestinal Microecology in Hyperuricemia and Traditional Chinese Medicine Intervention：A Review

Effect of Rhei Radix et Rhizoma Before and After Steaming with Wine on Intestinal Flora and Immune Environment in Constipation Model Mice

Related Author

JIANG Shengnan

WU Qifeng

WANG Zining

PU Hao

YAN Guiming

TIAN Dandan

WANG Shanping

YANG Li

Related Institution

College of Pharmacy，Anhui University of Chinese Medicine

School of Integrated Chinese and Western Medicine，Anhui University of Chinese Medicine

Geriatric Care and Health Laboratory，Anhui University of Chinese Medicine

The First Affiliated Hospital of Anhui University of Chinese Medicine

The First Affiliated Hospital of Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰